title: Do we need to measure specific antibodies in patients with limbic encephalitis?
authors.affiliation: From Hospital Clinic-IDIBAPS (J.D.), University of Barcelona; Catalan Institution for Research and Advanced Studies (ICREA) (J.D.), Barcelona, Spain; Department of Neurology (J.D.), University of Pennsylvania, Philadelphia; and Nuffield Department of Clinical Neurosciences (A.V.), John Radcliffe Hospital, University of Oxford, UK. Jdalmau@clinic.ub.es angela.vincent@ndcn.ox.ac.uk.
authors.forename: Josep
authors.initials: J
authors.lastname: Dalmau
authors.affiliation: From Hospital Clinic-IDIBAPS (J.D.), University of Barcelona; Catalan Institution for Research and Advanced Studies (ICREA) (J.D.), Barcelona, Spain; Department of Neurology (J.D.), University of Pennsylvania, Philadelphia; and Nuffield Department of Clinical Neurosciences (A.V.), John Radcliffe Hospital, University of Oxford, UK. Jdalmau@clinic.ub.es angela.vincent@ndcn.ox.ac.uk.
authors.forename: Angela
authors.initials: A
authors.lastname: Vincent
mesh_terms: D000906:Antibodies; D001323:Autoantibodies; D006801:Humans; D020363:Limbic Encephalitis
chemical_list: D000906:Antibodies; D001323:Autoantibodies